Clinical trials
Active, not recruiting clinical trials
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
Phase: 2
Disease: Alopecia Universalis (AU), Alopecia Totalis (AT)
Location(s): United States, New York
Request more information about this clinical trial.
All fields required.
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)
Phase: 4
Disease: Seborrheic Keratosis
Location(s): Pennsylvania, Tennessee, Texas
Request more information about this clinical trial.
All fields required.
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
Phase: 2
Disease: Dermatosis Papulosa Nigra
Location(s): District of Columbia, New York
Request more information about this clinical trial.
All fields required.
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
Phase: 2
Disease: Androgenetic Alopecia
Location(s): Colorado, Oregon, Texas
Request more information about this clinical trial.
All fields required.
Recruiting clinical trials
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Phase: 2
Disease: Alopecia Areata, Alopecia Totalis, Alopecia Universalis
Location(s): United States, Florida
Request more information about this clinical trial.
All fields required.
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Phase: 2
Disease: Alopecia Areata, Alopecia Universalis, Alopecia Totalis
Location(s):
Request more information about this clinical trial.
All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
Phase: 2
Disease: vitiligo
Location(s):
Request more information about this clinical trial.
All fields required.
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
Phase: 2
Disease: alopecia areata
Location(s):
Request more information about this clinical trial.
All fields required.
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Phase: 2
Disease: Atopic Dermatitis
Location(s):
Request more information about this clinical trial.
All fields required.
THWART-1 Study of A-101 Topical Solution for the Treatment of Common Warts
THWART-1 Study of A-101 Topical Solution for the Treatment of Common Warts
Phase: 3
Disease: Common Wart
Location(s):
Request more information about this clinical trial.
All fields required.
THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts
THWART-2 A Study of A-101 Topical Solution for the Treatment of Common Warts
Phase: 3
Disease: Common Wart
Location(s):
Request more information about this clinical trial.
All fields required.